A 6-year-old boy with Wilson disease-A diagnostic dilemma

Ramaswamy Ganesh1, N Suresh2, T Vasanthi2

  • 1Kanchi Kamakoti CHILDS Trust Hospital and The CHILDS Trust Medical Research Foundation, 12-A, Nageswara Road, Nungambakkam, Chennai, 600 034, India. ganeped79@rediffmail.com.

Insights

Diagnosing Wilson disease (WD) in children can be challenging due to overlapping symptoms with other liver conditions. Genetic testing of the ATP7B gene confirmed WD in a 6-year-old boy with atypical presentation.

Area of Science:

  • Pediatric Hepatology
  • Medical Genetics
  • Clinical Diagnostics

Background:

  • Wilson disease (WD) is an autosomal recessive disorder of copper metabolism, often presenting with diverse clinical manifestations in children.
  • Early diagnosis and treatment are crucial to prevent irreversible liver damage and neurological complications.
  • Diagnostic challenges arise from atypical presentations that mimic other pediatric liver diseases like autoimmune hepatitis and Indian childhood cirrhosis.

Observation:

  • A 6-year-old boy presented with progressive abdominal distension, jaundice, ascites, hepatosplenomegaly, and coagulopathy.
  • Initial investigations, including viral markers, Kayser-Fleischer ring examination, serum ceruloplasmin, and urinary copper levels, were inconclusive.
  • Liver biopsy revealed micronodular cirrhosis with Mallory hyaline and copper deposits, while serology showed positive anti-smooth muscle antibodies.

Findings:

  • Despite features suggestive of Indian childhood cirrhosis and autoimmune hepatitis, genetic analysis identified a pathogenic p.R969Q mutation in the ATP7B gene.
  • This genetic finding definitively confirmed the diagnosis of Wilson disease (WD).
  • The case highlights the critical role of genetic testing in resolving diagnostic dilemmas in pediatric WD.

Implications:

  • This case underscores the importance of considering Wilson disease in the differential diagnosis of pediatric liver failure, even with atypical clinical and biochemical profiles.
  • Integrated diagnostic approaches combining clinical, biochemical, histological, and genetic evaluations are essential for accurate WD diagnosis in children.
  • Improved diagnostic strategies can lead to earlier intervention, better patient outcomes, and reduced morbidity associated with Wilson disease.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
963
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294